SCHEMBL22509702

SCHEMBL22509702

Cc1cnc2cc(OC[C@@]34C[C@@H]3[C@@H](n3ccc5c(N)ncnc53)[C@@H]3OC(C)(C)O[C@@H]34)ccn12

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 0.56
▸ WDR77 Q9BQA1 19/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254253 1.00 PRMT5 (0.56) PRMT5WDR77
SCHEMBL22509700 0.91 PRMT5 (0.47) PRMT5WDR77
SCHEMBL23405222 0.87 PRMT5 (0.53) PRMT5WDR77
SCHEMBL22521507 0.84 PRMT5 (0.58) PRMT5WDR77
SCHEMBL22521484 0.84 PRMT5 (0.58) PRMT5WDR77
SCHEMBL22521493 0.84 PRMT5 (0.55) PRMT5WDR77
SCHEMBL24254158 0.84 PRMT5 (0.46) PRMT5WDR77
SCHEMBL22509882 0.82 PRMT5 (0.43) PRMT5WDR77
SCHEMBL22521415 0.76 PRMT5 (0.46) PRMT5WDR77
SCHEMBL23429828 0.74 PRMT5 (0.58) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048922-A1 COMPOUNDS TARGETING PRMT5 ALIGOS THERAPEUTICS, INC. 2022-02-17 — — US disclosed
WO-2020205867-A1 COMPOUNDS TARGETING PRMT5 ALIGOS THERAPEUTICS, INC. (US) 2020-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048922-A1 COMPOUNDS TARGETING PRMT5 PRMT5, PRMT1, PRMT6 PRMT5 1/4885WDR77 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback